Health Care/Hospital
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...
2020-06-01 07:30
2673
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies
SUZHOU, China and ROCKVILLE, Md., May 31, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company presented fo...
2020-05-31 20:00
2372
Fosun Foundation and Longfor Group donated 40 ventilators to the U.S. hospitals in fight against COVID-19
NEW YORK, May 29, 2020 /PRNewswire/ -- Fosun Foundation together with Longfor Group announce the donation of 40 Breas Vivo 50 ventilators to the hospitals in 21 hospitals located in 11 different states of U.S. to support medical communities fighting againse the COVID-19. The donated 40 ventila...
2020-05-30 02:00
2941
Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO)
SUZHOU, China and SHANGHAI, May 29, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, today announced that two presentations were accepted at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program. ...
2020-05-29 20:00
2133
I-Mab Announces Upcoming Participation at June Conferences
SHANGHAI and GAITHERSBURG, Md., May 29, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical ...
2020-05-29 20:00
6192
Mundane Glory: Telling the Story of Chinese Overseas Medical Aid
CHANGSHA, China, May 29, 2020 /PRNewswire/ -- Aired in Mango TV, Mundane Glory
is a series of short documentary that focuses on strivers who work on Chinese
emerging industry. It has been aired in global platforms including Mango TV and
Hunan Satellite TV sinceMay 21st of this year.
2020-05-29 17:41
1810
WorkJam Launches Next-Generation Health Check Analysis Tool, Advancing the Safety of Frontline Workforces
Industry-leading digital workplace platform introduces new tool to reduce the spread of COVID-19 among frontline employees and their customers MONTREAL, May 28, 2020 /PRNewswire/ -- WorkJam, the leading digital workplace solutions provider for organizations with frontline employees, today announc...
2020-05-28 21:00
2078
Seaweed Extract Offers Hope for Influenza A
CAMBRIDGE, Australia, May 28, 2020 /PRNewswire/ -- Australian scientists have revealed that a natural compound found in seaweed may reduce the effects of severe cases of Influenza A. Fucoidan is a highly bioactive compound found naturally in brown seaweed and well known for its diverse therapeu...
2020-05-28 15:30
1199
Shanghai Cell Therapy Group Launches Collaboration with USC researcher to Improve the ex vivo Expansion of Hematopoietic Stem Cells for Clinical Applications
SHANGHAI, May 27, 2020 /PRNewswire/ -- Shanghai Cell Therapy Group (SHCell) recently entered into a six-year research collaborative project with Professor Qi-Long Ying from theUniversity of Southern California (USC). Through the project, sponsored by$3.6 million from the Baize Plan Fund, the Ying...
2020-05-28 10:35
1243
I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome
SHANGHAI and GAITHERSBURG, MD, May 27, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced interim results from a multi-center, double blinded, randomized, placeb...
2020-05-28 04:05
1920
Transcenta Presents First Data from Phase 1 Study of pH-Dependent PDL1 Antibody MSB2311 in Patients with Pre-treated Advanced Solid Tumors and Select Hematological Malignancies
SUZHOU, China, May 27, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery,development and manufacturing of antibody-based therapeutics, announced today results reported for the first time from a Phase 1...
2020-05-27 23:00
1246
Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference
AUSTIN, May 27, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that President and Chief Executive Officer,Cameron Reynolds has been invited to present at The Role of Cell Therapy and Clarity on Testing Conference organised by the Maxim Group. Event Det...
2020-05-27 20:45
10043
IT Tech Packaging, Inc. Signs Letter of Intent to Acquire Intelligent Healthcare IT Solution Provider
BAODING, China, May 27, 2020 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE MKT: ITP) ("IT Tech Packaging" or "the Company"), a leading manufacturer and distributor of diversified paper products inNorth China, today announced that its operating entity inChina, Hebei Baoding Dongfang Paper Milling ...
2020-05-27 20:00
10718
United Imaging uMR OMEGA Cleared by FDA, Available in U.S. Market
HOUSTON, May 26, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced U.S. Food & Drug Administration (FDA) clearance of the uMR OMEGATM magnetic resonance imaging (MRI) scanner. The uMR OMEGA offers the world's first ultra-wide 75...
2020-05-26 20:00
1547
Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets
AMBLER, Pa., May 25, 2020 /PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered into a research agreement with Genmab A/S of Denmark to create and develop bispecific antibodies using Genmab's Du...
2020-05-25 22:00
1566
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock
AUSTIN, Texas, May 22, 2020 /PRNewswire/ -- VolitionRx Limited
2020-05-23 04:01
11332
Mayne Pharma launches BAC 300 capsules in the United States
ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg inthe United States. Mayne Pharma received approval from the US Food and Drug Administration for its Abb...
2020-05-22 13:44
5677
Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport
TOKYO, May 22, 2020 /PRNewswire/ -- Nippon Express (UK) Co., Ltd. (hereinafter, "NEUK"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has been officially granted Wholesale Distribution Authorisation (WDA) and Good Distribution Practice (GDP) certification for its warehouse near L...
2020-05-22 13:00
1516
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio
LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Samsung Biologics (207940.KS) have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK's innovative biopharmaceutical therapies. Under the terms of th...
2020-05-22 07:11
6488
Transcenta Announces to Present Preclinical Data of TST001 at 2020 AACR Virtual Annual Meeting II
SUZHOU, China, May 21, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, development and manufacturing, today announced that it will present preclinical data of TST001, a humanized Claudin 18.2 (CLDN18.2) monoclonal ...
2020-05-21 23:00
1634
Week's Top Stories
Most Reposted
UTP LAUNCHES MALAYSIA'S FIRST BACHELOR IN INTEGRATED ENGINEERING PROGRAMME
[Picked up by 305 media titles]
2024-12-27 13:17
XTransfer and OCBC Jointly Announce Comprehensive Partnership
[Picked up by 266 media titles]
2024-12-23 17:36
CKGSB Successfully Hosts 2024 MBA Professor Training Program for Western China
[Picked up by 253 media titles]
2024-12-24 00:06ebm-papst A&NZ Achieves Complete Operational Carbon Neutrality in appropriate Scope 1,2 and 3 criterion in 2023
[Picked up by 246 media titles]
2024-12-25 15:45Huawei Cloud Named a Challenger in Gartner® Magic Quadrant™ for Cloud DBMSs
[Picked up by 239 media titles]
2024-12-27 11:24
Most Read
/C O R R E C T I O N -- Ellington Properties/
2024-12-27 20:57
7420
XTransfer and OCBC Jointly Announce Comprehensive Partnership
2024-12-23 17:36
5814
CKGSB Successfully Hosts 2024 MBA Professor Training Program for Western China
2024-12-24 00:06
5018
Zoomlion Releases the World's Tallest Straight Boom Aerial Work Platform
2024-12-24 17:56
4829
